Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Immunotherapy for Metastatic Cancer Patients by Adoptive Transfer of Autologous IKDC-like Cells - Phase 1 Clinical Trial

NCT02661685 is registered in ClinicalTrials.gov with National Defense Medical Center, Taiwan as lead sponsor.

NCT NCT02661685
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02661685 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Immunotherapy for Metastatic Cancer Patients by Adoptive Transfer of Autologous IKDC-like Cells - Phase 1 Clinical Trial
Lead sponsor
National Defense Medical Center, Taiwan
Phase
Phase 1
Overall status
Completed
Start date
May 31, 2016
Completion date
October 31, 2019
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neoplasm metastasis